The U.S. clinical trials supply and logistics market size was exhibited at USD 1,319 million in 2024 and is projected to hit around USD 2,744 million by 2034, growing at a CAGR of 7.6% during the forecast period 2024 to 2034.
The U.S. is considered to be a global leader in conduction of clinical trials. The dominance can be attributed to robust pharmaceutical industry with major market players, large population pool, well-established network of investigators, rising investments in R&D and a high number of ongoing clinical trials conducted across various therapeutics areas. These factors overall contribute to the high demand of supply and logistics for smooth conduction of clinical trials in the U.S.
The U.S. clinical trials supply and logistics market is involved in the complex process of management and distribution of numerous medical supplies such as drugs, instruments, kits and devices required for the conduction of clinical trials across the United States. While adhering to the stringent regulatory guidelines for procurement, storage, transportation and delivery of supplies to research sites and the expansion of several research sites for clinical research within the country is significantly contributing to the market growth.
Moreover, the rising public awareness about the importance of clinical trials for developing effective and innovative treatments for chronic diseases, increased support from government bodies, growing participation of volunteers’ in clinical trials and involvement of researchers and clinicians from various pharmaceutical companies, research organizations and academic institutes is fuelling the progress of clinical trials.
Furthermore, the advancements in supply chain technology have streamlined distribution process including the acquisition of clinical trial materials, packaging and labelling of materials in accordance with regulatory guidelines and patient standards, maintenance of inventory levels, proper storage conditions and timely delivery of materials while monitoring and tracking the status of shipments with technology throughout the supply chain.
However, the complex regulatory requirements implemented by the U.S. Food and Drug Administration (FDA), issues in supply chain, specialized requirements for transport and storage of materials, management of various clinical trial sites, errors in labelling and documentation processes and inefficiency in development of contingency plans can potentially disrupt the conduction of clinical trials leading to delay in clinical research process, increased costs and also in withdrawal of participants.
To ensure the success of clinical trials it is essential to carefully plan and predict the needs while ensuring the various factors in designing of kits required. Understanding and consideration of upstream planning activities for forecasting the demand of clinical supplies can help in developing strategies for clinical trials. Factors such as budget, risk threshold and time pressure are critical for pharmaceutical and biopharmaceutical companies for making the right decisions while commencing a clinical trial.
Additionally, initiatives led by the U.S. government for improving clinical trials such as the Advancing Clinical Trials Readiness for Health (ARPA-H) for enhancing the speed and dependability of clinical trials, setup of the National Clinical Trials Network (NCTN), FDA guidance and the National Institutes of Health (NIH) which is the largest federal funder of clinical trials in the U.S. These initiatives assist in advancing the clinical trials network while ensuring the safety of participants in clinical trials.
The rising trend of outsourcing clinical supplies from pharmaceutical CDMOs (Contract Development and Manufacturing Organizations) in the U.S. by various pharmaceutical and biopharmaceutical companies for meeting the requirements of clinical trials while ensuring the quality and regulatory compliance of these materials is expected to drive the supply and logistics market. With the increased dependence on CDMOs for meeting supply needs helps the clinical research organizations (CROs) and pharmaceutical companies to focus on the R&D process for advancing the process the of clinical trials.
Increased success rates of clinical trials, accelerated approvals from the FDA, globalization of clinical trials, robust product pipelines by companies, adoption of innovative technologies for smooth conduction of clinical trials and active involvement of various industries and government bodies is creating opportunities for the U.S. clinical trial supply and logistics market.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
| Stats ID: | 7622 |
| Format: | Databook |
| Published: | January 2025 |
| Price | US$ 1550 |
Immediate Delivery
| Stats ID: | 7622 |
| Format: | Databook |
| Published: | January 2025 |
| Price | US$ 1550 |
Immediate Delivery
Unlock unlimited access to all exclusive market research reports, empowering your business.
Get industry insights at the most affordable plan
Stay ahead of the competition with comprehensive, actionable intelligence at your fingertips!
Learn More
